News - Neupro

Filter

Current filters:

Neupro

Popular Filters

Leading dopamine agonists will continue to dominate Parkinson's market

19-08-2012

The leading dopamine agonists, pramipexole (Boehringer Ingelheim's Mirapex/Mirapexin/Sifrol/BI-Sifrol,…

Boehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingMirapexNeuproNeurologicalPharmaceuticalRequipRytaryUCB

UCB's Neupro re-launched in USA for Parkinson's and RSL

16-07-2012

Belgium drugmaker UCB (Euronext Brussels: UCB) said yesterday that its Neupro (rotigotine transdermal…

Markets & MarketingNeuproNeurologicalNorth AmericaPharmaceuticalUCB

FDA approves UCB drug Neupro for PD and RLS

03-04-2012

Belgian drugmaker UCB (Euronext Brussels: UCB) said yesterday that the US Food and Drug Administration…

NeuproNeurologicalNorth AmericaPharmaceuticalRegulationUCB

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top